Microsoft Corporation (NASDAQ: MSFT) was hit with another setback Monday over its bid to acquire Activision Blizzard, Inc (NASDAQ: ATVI), this time from the European Commission, which has concerns surrounding the deal.<
AstraZeneca's Tezspire (tezepelumab) has received a positive opinion from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.